Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the full record of transactions filed by Love Ted W. Insider active across 5 companies, notably Seagen Inc.. In total, 28 disclosures have been logged. Split: 3 buys · 0 sell. History available since 14 May 2021. The latest transaction was filed on 5 August 2026 (Attribution). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Love Ted W
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
LOVE TED W is a declarant linked to Global Blood Therapeutics, Inc., Royalty Pharma plc, Seagen Inc., Gilead Sciences, INC., and Jazz Pharmaceuticals plc, with the listed role of President and CEO for Global Blood Therapeutics, Inc. and Director for the other listed companies. He has made 27 filings in total, and among the recent sampled filings there are sales of EUR 971066 between 2016-01-07 and 2026-03-02, with the transaction nature listed as Attribution.